n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Body Weight in 12 studies
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Following trauma, increased prostaglandin E2 (PGE2) levels may be important in immunodysregulation." | 1.31 | Blocking prostaglandin E2 after trauma attenuates pro-inflammatory cytokines and improves survival. ( Concannon, EM; Daly, JM; Mackrell, PJ; Naama, HA; Schaefer, PA; Shaftan, GW; Stapleton, PP; Strong, VE, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 7 (58.33) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nasrallah, R | 1 |
| Robertson, SJ | 1 |
| Hébert, RL | 1 |
| Fathali, N | 1 |
| Ostrowski, RP | 1 |
| Lekic, T | 1 |
| Jadhav, V | 1 |
| Tong, W | 1 |
| Tang, J | 1 |
| Zhang, JH | 1 |
| Mingorance, C | 1 |
| de Sotomayor, MA | 1 |
| Marhuenda, E | 1 |
| Herrera, MD | 1 |
| Sugiyama, T | 1 |
| Meakin, LB | 1 |
| Galea, GL | 1 |
| Lanyon, LE | 1 |
| Price, JS | 1 |
| Sugimoto, K | 1 |
| Iadecola, C | 1 |
| Harding, P | 1 |
| Glass, WF | 1 |
| Scherer, SD | 1 |
| Vanecková, I | 1 |
| Skaroupková, P | 1 |
| Dvorák, P | 1 |
| Certíková Chábová, V | 1 |
| Tesar, V | 1 |
| Bader, M | 1 |
| Ganten, D | 1 |
| Kramer, HJ | 1 |
| Takahashi, T | 1 |
| Zhu, SJ | 1 |
| Sumino, H | 1 |
| Saegusa, S | 1 |
| Nakahashi, T | 1 |
| Iwai, K | 1 |
| Morimoto, S | 1 |
| Kanda, T | 1 |
| Yoshimi, N | 2 |
| Kawabata, K | 1 |
| Hara, A | 2 |
| Matsunaga, K | 2 |
| Yamada, Y | 2 |
| Mori, H | 2 |
| Shimizu, M | 1 |
| Fujii, K | 1 |
| Strong, VE | 1 |
| Mackrell, PJ | 1 |
| Concannon, EM | 1 |
| Naama, HA | 1 |
| Schaefer, PA | 1 |
| Shaftan, GW | 1 |
| Stapleton, PP | 1 |
| Daly, JM | 1 |
| Fain, JN | 1 |
| Ballou, LR | 1 |
| Bahouth, SW | 1 |
12 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Body Weight
| Article | Year |
|---|---|
Chronic COX inhibition reduces diabetes-induced hyperfiltration, proteinuria, and renal pathological markers in 36-week B6-Ins2(Akita) mice.
Topics: Albuminuria; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Body Weight; Creatinine; | 2009 |
Cyclooxygenase-2 inhibition provides lasting protection against neonatal hypoxic-ischemic brain injury.
Topics: Animals; Animals, Newborn; Behavior, Animal; Blotting, Western; Body Weight; Brain; Cyclooxygenase 2 | 2010 |
Chronic treatment with the cannabinoid 1 antagonist rimonabant altered vasoactive cyclo-oxygenase-derived products on arteries from obese Zucker rats.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Body Weight; Endothelium, Vascular; Nitric Oxide Synthase T | 2010 |
The cyclooxygenase-2 selective inhibitor NS-398 does not influence trabecular or cortical bone gain resulting from repeated mechanical loading in female mice.
Topics: Adaptation, Physiological; Animals; Body Weight; Cyclooxygenase 2 Inhibitors; Female; Fibula; Mice; | 2013 |
Delayed effect of administration of COX-2 inhibitor in mice with acute cerebral ischemia.
Topics: Acute Disease; Animals; Body Temperature; Body Weight; Brain Ischemia; Cyclooxygenase 2; Cyclooxygen | 2003 |
COX-2 inhibition potentiates the antiproteinuric effect of enalapril in uninephrectomized SHR.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Wei | 2003 |
Effects of sodium restriction and cyclooxygenase-2 inhibition on the course of hypertension, proteinuria and cardiac hypertrophy in Ren-2 transgenic rats.
Topics: Animals; Animals, Genetically Modified; Blood Pressure; Body Weight; Cardiomegaly; Cyclooxygenase In | 2005 |
Inhibition of cyclooxygenase-2 enhances myocardial damage in a mouse model of viral myocarditis.
Topics: Adiponectin; Animals; Body Weight; Cardiovirus Infections; Cyclooxygenase 2; Cyclooxygenase 2 Inhibi | 2005 |
Inhibitory effect of NS-398, a selective cyclooxygenase-2 inhibitor, on azoxymethane-induced aberrant crypt foci in colon carcinogenesis of F344 rats.
Topics: Animals; Anticarcinogenic Agents; Azoxymethane; Body Weight; Carcinogens; Colon; Colonic Neoplasms; | 1997 |
Chemopreventive effect of N-(2-cyclohexyloxy-4-nitrophenyl)methane sulfonamide (NS-398), a selective cyclooxygenase-2 inhibitor, in rat colon carcinogenesis induced by azoxymethane.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Azoxymethane; Body Weight; Carcinogens; Chemopreve | 1999 |
Blocking prostaglandin E2 after trauma attenuates pro-inflammatory cytokines and improves survival.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Cyclooxygenase 2; Cyclooxygenase 2 In | 2000 |
Obesity is induced in mice heterozygous for cyclooxygenase-2.
Topics: 6-Ketoprostaglandin F1 alpha; Adipose Tissue; Animals; Body Weight; Cyclooxygenase 1; Cyclooxygenase | 2001 |